Author:
Bhat Gh. Rasool,Hyole Rosalie G.,Li Jiong
Reference123 articles.
1. A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck;Abdul Razak;Annals of Oncology,2013
2. Clinical update on head and neck cancer: Molecular biology and ongoing challenges;Alsahafi;Cell Death & Disease,2019
3. Receptor-mediated tobacco toxicity: Cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of a7 nicotinic receptor in oral keratinocytes;Arredondo;The FASEB Journal,2006
4. IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade;Ayers;The Journal of Clinical Investigation,2017
5. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density;Beasley;Cancer Research,2001
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献